| D004335 |
Drug and Narcotic Control |
Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs. |
Drug Regulations,Narcotic Control,Pharmaceutical Policy,Drug Control,Narcotic and Drug Control,Pharmaceutic Policy,Control, Drug,Control, Narcotic,Controls, Drug,Controls, Narcotic,Drug Controls,Drug Regulation,Narcotic Controls,Pharmaceutical Policies,Policies, Pharmaceutical,Policy, Pharmaceutical,Regulation, Drug,Regulations, Drug |
|
| D006113 |
United Kingdom |
Country in northwestern Europe including Great Britain and the northern one-sixth of the island of Ireland, located between the North Sea and north Atlantic Ocean. The capital is London. |
Great Britain,Isle of Man |
|
| D006291 |
Health Policy |
Decisions, usually developed by government policymakers, for determining present and future objectives pertaining to the health care system. |
Health Care Policies,Health Policies,Healthcare Policy,National Health Policy,Care Policies, Health,Health Care Policy,Health Policy, National,Healthcare Policies,National Health Policies,Policies, Health,Policies, Health Care,Policies, Healthcare,Policy, Health,Policy, Health Care,Policy, Healthcare |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D013222 |
State Medicine |
A system of medical care regulated, controlled and financed by the government, in which the government assumes responsibility for the health needs of the population. |
National Health Service, British,Socialized Medicine,British Health Service, National,British National Health Service,Medicine, Socialized,Medicine, State,Service, British National Health |
|
| D015397 |
Program Evaluation |
Studies designed to assess the efficacy of programs. They may include the evaluation of cost-effectiveness, the extent to which objectives are met, or impact. |
Evaluation, Program,Family Planning Program Evaluation,Program Appropriateness,Program Effectiveness,Program Sustainability,Appropriateness, Program,Effectiveness, Program,Evaluations, Program,Program Evaluations,Program Sustainabilities,Sustainabilities, Program,Sustainability, Program |
|
| D015658 |
HIV Infections |
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). |
HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human |
|
| D015819 |
Substance Abuse, Intravenous |
Abuse, overuse, or misuse of a substance by its injection into a vein. |
Drug Abuse, Intravenous,Drug Abuse, Parenteral,Intravenous Drug Abuse,Intravenous Substance Abuse,Parenteral Drug Abuse |
|
| D018671 |
Needle-Exchange Programs |
Organized services for exchange of sterile needles and syringes used for injections as a potential means of reducing the transmission of infectious diseases. |
Needle-Exchange Program,Supervised Injecting Centers,Supervised Injecting Facilities,Supervised Injecting Facility,Syringe-Exchange Program,Syringe-Exchange Programs,Center, Supervised Injecting,Centers, Supervised Injecting,Facilities, Supervised Injecting,Facility, Supervised Injecting,Injecting Center, Supervised,Injecting Centers, Supervised,Injecting Facilities, Supervised,Injecting Facility, Supervised,Needle Exchange Program,Needle Exchange Programs,Program, Needle-Exchange,Program, Syringe-Exchange,Programs, Needle-Exchange,Programs, Syringe-Exchange,Supervised Injecting Center,Syringe Exchange Program,Syringe Exchange Programs |
|
-transparent.png){kind=logo}
